Novo Nordisk Owner to Plow Obesity Drug Profit Into Green Market
The shareholder that controls Novo Nordisk A/S is responding to a downturn in green assets by ratcheting up investments with profits from the obesity drugmaker. #press

Novo Nordisk Owner to Plow Obesity Drug Profit Into Green Market
The shareholder that controls Novo Nordisk A/S is responding to a downturn in green assets by ratcheting up investments with profits from the obesity drugmaker. #press

No replies yet.